Skip to main content
Livermore
Livermore
ZHEN

Clover Health Investments, Corp.

CLOV
Exchange
Nasdaq
Industry
Hospital & Medical Service Plans
SEC CIK
0001801170

In the last 90 days, Clover Health Investments, Corp. insiders filed 0 open-market purchases and 18 sales; 227 institutions reported holding it in 13F filings for Q2 2026, worth $762.5M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Clover Health Investments, Corp. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
18 filings
6 insiders, $4.61M in total
Insiders trading
6
Net value
−$4.61M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Clover Health Investments, Corp., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Clover Health Investments, Corp.
NameTitleLast reported holdingLast filingFilings, past year
Reynoso Jamie L.CEO, Medicare Advantage2,803,446Sep 18, 202624
Oldakowski Joseph FrankVP OF FINANCE AND CONTROLLER275,897Sep 17, 20263
Wai ConradCEO, Counterpart Health1,170,056IndirectSep 16, 202610
Soares KarenChief Legal Officer1,607,371Sep 15, 202614
Thornton Joseph ClayInterim CFO1,249,526Aug 17, 20265
Toy AndrewChief Executive Officer9,459,316Aug 10, 202612
Edwards Carladenise ArmbristerDirector285,432May 19, 20262
Priest Brady PatrickCEO of Clover Care Services2,040,222May 13, 20269
Kuipers Peter J.Chief Financial Officer5,758,353Feb 2, 20262
Garipalli VivekDirector, 10% Owner1,856,247Jan 9, 20261
Tran Thomas LDirector180,029Jan 8, 20261
Robinson William G JrDirector597,987Jan 8, 20261
Kouzoukas Demetrios L.Director605,980Jan 8, 20261
Loengard Anna UDirector527,456Jan 8, 20261
Shapiro LeeDirector598,622Jan 8, 20250
Clinton ChelseaDirector602,814Jan 8, 20250
Sharp Aric RCEO of Value Based Care2,100,665Aug 13, 20240
Leffler Scott J.Chief Financial Officer4,857,303Jan 29, 20240
Clover Health Investments, Corp.Chief Technology Officer3,093,225Nov 2, 20230
Martin Joseph RichardsGeneral Counsel2,718,857Jun 16, 20230
Singh PrabhdeepChief Growth Officer872,821Sep 20, 20220
Turner Nathaniel S.Director–Feb 22, 20220
Palihapitiya Chamath10% Owner, Other: See Remarks1,739,130IndirectNov 24, 20210
SCH Sponsor III LLC10% Owner, Other: Former Director1,739,130IndirectNov 24, 20210
ChaChaCha SPAC C, LLC10% Owner, Other: Former Director1,739,130IndirectNov 24, 20210
Peretz Benjamin10% Owner–Nov 24, 20210
Greenoaks Capital Partners LLC10% Owner, Other: See Remarks–Nov 24, 20210
Mehta Neil10% Owner–Nov 24, 20210
Wagner Joseph F.Chief Financial Officer25,000Aug 11, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 15, 2026 (view filing)8:11 PM ETSep 15Same daySoares KarenChief Legal OfficerSSaleClass A Common Stock−6.85K$4.78−$32.7K−0.4%1.61M after10b5-1
Sep 16, 2026 (view filing)4:27 PM ETSep 151 dayWai ConradCEO, Counterpart HealthSSaleClass A Common Stock−300.0K$4.72−$1.42M−20.4%1.17M after10b5-1
Sep 17, 2026 (view filing)5:29 PM ETSep 161 dayOldakowski Joseph FrankVP OF FINANCE AND CONTROLLERSSaleClass A Common Stock−3.17K$4.64−$14.7K−1.1%275.9K after10b5-1
Sep 18, 2026 (view filing)4:22 PM ETSep 171 dayReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−1.92K$4.56−$8.76K−0.1%2.80M after10b5-1